WO2009045360A3 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells - Google Patents
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells Download PDFInfo
- Publication number
- WO2009045360A3 WO2009045360A3 PCT/US2008/011251 US2008011251W WO2009045360A3 WO 2009045360 A3 WO2009045360 A3 WO 2009045360A3 US 2008011251 W US2008011251 W US 2008011251W WO 2009045360 A3 WO2009045360 A3 WO 2009045360A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- placental perfusate
- natural killer
- cells
- human
- derived intermediate
- Prior art date
Links
- 230000003169 placental effect Effects 0.000 title abstract 5
- 210000000822 natural killer cell Anatomy 0.000 title abstract 3
- 210000002826 placenta Anatomy 0.000 title abstract 3
- 230000005760 tumorsuppression Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/48—Blood cells, e.g. leukemia or lymphoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/49—Breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/52—Intestine
Abstract
Priority Applications (30)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020237014071A KR20230065354A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
BRPI0817751A BRPI0817751A2 (en) | 2007-09-28 | 2008-09-29 | method for suppressing tumor cell proliferation, and, composition |
ES08834753T ES2530995T3 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and intermediate natural killer cells that come from human placenta |
RS20150132A RS53841B1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
KR1020217033153A KR20210127819A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
AU2008307633A AU2008307633C1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
MX2010003291A MX2010003291A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells. |
KR1020217004990A KR20210022148A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
SI200831388T SI2203176T1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
KR1020227028095A KR20220119515A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
EP13188706.9A EP2783692B1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
RU2010116757/15A RU2536242C2 (en) | 2007-09-28 | 2008-09-29 | Tumour suppression with use of human placental perfusate and auxiliary natural killer cells recovered from human placenta |
KR1020177025849A KR101955140B1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
KR1020187027232A KR20180107320A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
CA2700617A CA2700617C (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
MX2013000346A MX349144B (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells. |
KR1020197034127A KR20190132556A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
PL08834753T PL2203176T3 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
DK08834753.9T DK2203176T3 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression with human placental perfusate and human natural killer cells of an intermediate product from placenta |
EP18215553.1A EP3524253A1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
KR1020167021613A KR20160098527A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
EP08834753.9A EP2203176B1 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
CN2008801183996A CN101878034B (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
JP2010526968A JP5795476B2 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
NZ584458A NZ584458A (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
IL204860A IL204860A (en) | 2007-09-28 | 2010-03-28 | Use of human placental perfusate comprising cd56+ placental intermediate natural killer cells for manufacture of a medicament |
ZA2010/02304A ZA201002304B (en) | 2007-09-28 | 2010-03-31 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
HK10106693.5A HK1139876A1 (en) | 2007-09-28 | 2010-07-09 | Tumor suppression using human placental perfusate and human placenta- derived intermediate natural killer cells |
HRP20150220AT HRP20150220T1 (en) | 2007-09-28 | 2015-02-26 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
IL250316A IL250316A0 (en) | 2007-09-28 | 2017-01-26 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99576307P | 2007-09-28 | 2007-09-28 | |
US60/995,763 | 2007-09-28 | ||
US9055508P | 2008-08-20 | 2008-08-20 | |
US61/090,555 | 2008-08-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009045360A2 WO2009045360A2 (en) | 2009-04-09 |
WO2009045360A3 true WO2009045360A3 (en) | 2009-07-23 |
Family
ID=40526873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/011251 WO2009045360A2 (en) | 2007-09-28 | 2008-09-29 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
Country Status (23)
Country | Link |
---|---|
US (3) | US8263065B2 (en) |
EP (3) | EP2783692B1 (en) |
JP (5) | JP5795476B2 (en) |
KR (10) | KR20190132556A (en) |
CN (3) | CN103599132A (en) |
AU (1) | AU2008307633C1 (en) |
BR (1) | BRPI0817751A2 (en) |
CA (2) | CA2700617C (en) |
DK (2) | DK2203176T3 (en) |
ES (2) | ES2719931T3 (en) |
HK (2) | HK1139876A1 (en) |
HR (1) | HRP20150220T1 (en) |
HU (1) | HUE024286T2 (en) |
IL (2) | IL204860A (en) |
MX (2) | MX2010003291A (en) |
NZ (3) | NZ584458A (en) |
PL (1) | PL2203176T3 (en) |
PT (1) | PT2203176E (en) |
RS (1) | RS53841B1 (en) |
RU (1) | RU2536242C2 (en) |
SI (1) | SI2203176T1 (en) |
WO (1) | WO2009045360A2 (en) |
ZA (1) | ZA201002304B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
KR100915482B1 (en) | 2000-12-06 | 2009-09-03 | 하리리 로버트 제이 | Method of collecting placental stem cells |
NZ528035A (en) | 2001-02-14 | 2005-07-29 | Robert J Hariri | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
EP1571910A4 (en) * | 2002-11-26 | 2009-10-28 | Anthrogenesis Corp | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
NZ550027A (en) * | 2004-03-26 | 2009-03-31 | Celgene Corp | Systems and methods for providing a stem cell bank |
EP2368973A1 (en) * | 2005-10-13 | 2011-09-28 | Anthrogenesis Corporation | Production Of Oligodendrocytes From Placenta-Derived Stem Cells |
ES2452595T3 (en) | 2005-10-13 | 2014-04-02 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US8455250B2 (en) * | 2005-12-29 | 2013-06-04 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
EP1974013A2 (en) | 2005-12-29 | 2008-10-01 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
PL2471904T3 (en) | 2005-12-29 | 2019-08-30 | Celularity, Inc. | Placental stem cell populations |
KR102651433B1 (en) | 2006-04-14 | 2024-03-25 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | Hemangio-colony forming cells |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
CA2850793A1 (en) | 2006-10-23 | 2008-05-02 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
EP2129775A1 (en) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
AU2008216749B2 (en) | 2007-02-12 | 2014-03-13 | Celularity Inc. | Treatment of inflammatory diseases using placental stem cells |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
EP2783692B1 (en) | 2007-09-28 | 2019-01-02 | Celularity, Inc. | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
TWI490214B (en) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
CN105796602A (en) | 2008-08-20 | 2016-07-27 | 人类起源公司 | Treatment of stroke using isolated placental cells |
MX2011001990A (en) | 2008-08-20 | 2011-03-29 | Anthrogenesis Corp | Improved cell composition and methods of making the same. |
CN102176919A (en) | 2008-08-22 | 2011-09-07 | 人类起源公司 | Methods and compositions for treatment of bone defects with placental cell populations |
KR20110086176A (en) | 2008-11-19 | 2011-07-27 | 안트로제네시스 코포레이션 | Amnion derived adherent cells |
NZ595440A (en) * | 2009-03-25 | 2014-05-30 | Anthrogenesis Corp | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
US20100323446A1 (en) | 2009-06-05 | 2010-12-23 | Jill Renee Barnett | Method of collecting placental cells |
CA2767014C (en) | 2009-07-02 | 2022-01-25 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
JP2013512195A (en) * | 2009-11-24 | 2013-04-11 | セルジーン コーポレイション | Immunomodulatory compounds for restoring vitamin D sensitivity in vitamin D resistant tumor cells |
US8822218B2 (en) * | 2009-12-04 | 2014-09-02 | Stem Cell & Regenerative Medicine International, Inc. | Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts |
ES2646750T3 (en) * | 2010-01-26 | 2017-12-15 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
CA2790333A1 (en) | 2010-02-18 | 2011-08-25 | Osiris Therapeutics, Inc. | Methods of manufacture of immunocompatible amniotic membrane products |
US20110280849A1 (en) * | 2010-03-26 | 2011-11-17 | Anthrogenesis Corporation | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
SI2556145T1 (en) | 2010-04-07 | 2017-01-31 | Anthrogenesis Corporation | Angiogenesis using placental stem cells |
KR20130092394A (en) | 2010-04-08 | 2013-08-20 | 안트로제네시스 코포레이션 | Treatment of sarcoidosis using placental stem cells |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
NZ605505A (en) | 2010-07-13 | 2015-02-27 | Anthrogenesis Corp | Methods of generating natural killer cells |
EP3443968A1 (en) | 2011-06-01 | 2019-02-20 | Celularity, Inc. | Treatment of pain using placental stem cells |
JP5572863B2 (en) | 2011-06-24 | 2014-08-20 | 国立大学法人九州大学 | Method for amplifying NK cells |
US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
EP3190186B1 (en) * | 2011-11-30 | 2023-12-13 | Jörn Bullerdiek | Expression of mirnas in placental tissue |
CA2859714C (en) * | 2011-12-23 | 2023-10-17 | Anthrogenesis Corporation | Organoids comprising decellularized and repopulated placental vascular scaffold |
EP2816894B1 (en) | 2012-02-23 | 2018-01-03 | Anthrogenesis Corporation | Identification of antitumor compounds using placenta |
AU2013204922B2 (en) | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
CA2896053A1 (en) | 2012-12-21 | 2014-06-26 | Ocata Therapeutics, Inc. | Methods for production of platelets from pluripotent stem cells and compositions thereof |
AU2014215458A1 (en) | 2013-02-05 | 2015-08-13 | Anthrogenesis Corporation | Natural killer cells from placenta |
AU2014298486B2 (en) * | 2013-07-30 | 2019-01-24 | Fresenius Kabi Deutschland Gmbh | Hydroxyalkyl starch for the treatment of hematological neoplasms |
WO2015031681A1 (en) * | 2013-08-30 | 2015-03-05 | Mimedx Group, Inc. | Micronized placental compositions comprising a chelator |
US10179152B2 (en) * | 2013-10-03 | 2019-01-15 | Celularity, Inc. | Therapy with cells from human placenta and hematopoietic cells |
AU2014348454A1 (en) | 2013-11-15 | 2016-06-02 | Celularity Inc. | Compositions comprising human placental perfusate cells, subpopulations thereof, and their uses |
AU2015217406A1 (en) * | 2014-02-11 | 2016-08-25 | Celularity Inc. | Micro-organoids, and methods of making and using the same |
WO2016007827A1 (en) | 2014-07-11 | 2016-01-14 | Anthrogenesis Corporation | Methods of improving vector transduction efficiency into t lymphocytes |
WO2016034679A1 (en) * | 2014-09-03 | 2016-03-10 | Drk Blutspendedienst Baden-Württemberg-Hessen Ggmbh | Micro rna for the suppression of blood group antigens |
WO2016149492A1 (en) * | 2015-03-18 | 2016-09-22 | Anthrogenesis Corporation | Methods of banking placental tissue and cells |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
US10137144B2 (en) | 2016-01-15 | 2018-11-27 | American Gene Technologies International Inc. | Methods and compositions for the activation of gamma-delta T-cells |
EP4310500A3 (en) | 2016-01-15 | 2024-04-03 | American Gene Technologies International Inc. | Methods and compositons for the activation of gamma-delta t-cells |
RU2613884C1 (en) * | 2016-02-08 | 2017-03-21 | Андрей Николаевич Николаенко | Method for cancer adoptive immunotherapy |
CA3012741A1 (en) * | 2016-02-18 | 2017-08-24 | Pluristem Ltd. | Methods and compositions for treating cancer and neoplasms |
CN106047806B (en) * | 2016-08-19 | 2019-07-16 | 上海逍鹏生物科技有限公司 | A kind of peripheral blood cells culture medium suitable for concentration cultivation system |
DE112017005579T5 (en) | 2016-11-04 | 2019-09-05 | Ihi Corporation | Valve mechanism with variable flow rate and turbocharger |
CN110913870A (en) * | 2016-12-30 | 2020-03-24 | 细胞结构公司 | Genetically modified natural killer cells |
CN108324945B (en) * | 2017-01-19 | 2020-09-08 | 首都医科大学附属北京妇产医院 | Inhibitor for inhibiting nano-drug particles from penetrating placenta barrier |
US20200246393A1 (en) | 2017-09-28 | 2020-08-06 | Celularity, Inc. | Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody |
JP2024503883A (en) * | 2021-01-21 | 2024-01-29 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | Engineered NK cells and methods of treating cancer |
CN113699107B (en) * | 2021-10-27 | 2022-02-01 | 东莞再立健生物科技有限公司 | Peripheral blood NKT cell culture solution and culture method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068306A1 (en) * | 2001-09-14 | 2003-04-10 | Dilber Mehmet Sirac | Medium |
US7045148B2 (en) * | 2000-12-06 | 2006-05-16 | Anthrogenesis Corporation | Method of collecting placental stem cells |
US20070041954A1 (en) * | 2005-07-14 | 2007-02-22 | Ichim Thomas E | Compositions of placentally-derived stem cells for the treatment of cancer |
US7255879B2 (en) * | 2000-12-06 | 2007-08-14 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
Family Cites Families (309)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US187337A (en) * | 1877-02-13 | Improvement in fence-posts | ||
US846765A (en) * | 1905-12-01 | 1907-03-12 | Betty Vogel | Fruit and vegetable peeling machine. |
US848007A (en) * | 1906-10-31 | 1907-03-26 | Fred A Brusseau | Clamp for base-ball covers. |
US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
US4829000A (en) | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US4798824A (en) | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5902741A (en) | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
NZ226750A (en) | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
GB8803697D0 (en) | 1988-02-17 | 1988-03-16 | Deltanine Research Ltd | Clinical developments using amniotic membrane cells |
US5284766A (en) * | 1989-02-10 | 1994-02-08 | Kao Corporation | Bed material for cell culture |
FR2646438B1 (en) | 1989-03-20 | 2007-11-02 | Pasteur Institut | A METHOD FOR SPECIFIC REPLACEMENT OF A COPY OF A GENE PRESENT IN THE RECEIVER GENOME BY INTEGRATION OF A GENE DIFFERENT FROM THAT OR INTEGRATION |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5763266A (en) | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
US5635386A (en) | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
DE69034263D1 (en) | 1989-07-25 | 2009-04-02 | Cell Genesys Inc | Homologous recombination for universal donor cells and mammalian chimeric cells |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
DK0747485T3 (en) | 1989-11-06 | 1999-08-16 | Cell Genesys Inc | Preparation of proteins using homologous recombination |
US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
US5744361A (en) * | 1991-04-09 | 1998-04-28 | Indiana University | Expansion of human hematopoietic progenitor cells in a liquid medium |
EP0552380A4 (en) | 1991-08-08 | 1995-01-25 | Kao Corp | Cell culture support, production thereof, and production of cell cluster using same |
EP0529751A1 (en) | 1991-08-09 | 1993-03-03 | W.R. Grace & Co.-Conn. | Cell culture substrate, test material for cell culture and preparations thereof |
WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5356373A (en) | 1991-11-15 | 1994-10-18 | Miles Inc. | Method and apparatus for autologous transfusions in premature infants |
US6057123A (en) | 1991-12-23 | 2000-05-02 | British Biotech Pharmaceuticals Limited | Stem cell inhibiting proteins |
US5668104A (en) | 1992-03-31 | 1997-09-16 | Toray Industries, Inc. | Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo |
US5552267A (en) | 1992-04-03 | 1996-09-03 | The Trustees Of Columbia University In The City Of New York | Solution for prolonged organ preservation |
US5436151A (en) | 1992-04-03 | 1995-07-25 | Regents Of The University Of Minnesota | Method for culturing human hematopoietic stem cells in vitro |
US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
AU4543193A (en) | 1992-06-22 | 1994-01-24 | Henry E. Young | Scar inhibitory factor and use thereof |
US5849553A (en) | 1992-07-27 | 1998-12-15 | California Institute Of Technology | Mammalian multipotent neural stem cells |
US5672346A (en) | 1992-07-27 | 1997-09-30 | Indiana University Foundation | Human stem cell compositions and methods |
US5693482A (en) | 1992-07-27 | 1997-12-02 | California Institute Of Technology | Neural chest stem cell assay |
EP0669974A1 (en) | 1992-11-16 | 1995-09-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Pluripotential quiescent stem cell population |
US5772992A (en) | 1992-11-24 | 1998-06-30 | G.D. Searle & Co. | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors |
US5654186A (en) | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
JPH08510997A (en) * | 1993-03-31 | 1996-11-19 | プロ−ニューロン,インコーポレイテッド | Stem cell growth inhibitors and uses thereof |
GB9308271D0 (en) | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5698579A (en) | 1993-07-02 | 1997-12-16 | Celgene Corporation | Cyclic amides |
US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
IL107483A0 (en) | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
US6001654A (en) | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
DE69531638T2 (en) * | 1994-06-06 | 2004-06-17 | Osiris Therapeutics, Inc. | BIOMATRIX FOR TISSUE REGENATION |
US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
DE4422667A1 (en) | 1994-06-30 | 1996-01-04 | Boehringer Ingelheim Int | Process for the production and cultivation of hematopoietic progenitor cells |
US6103522A (en) * | 1994-07-20 | 2000-08-15 | Fred Hutchinson Cancer Research Center | Human marrow stromal cell lines which sustain hematopoiesis |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5827742A (en) | 1994-09-01 | 1998-10-27 | Beth Israel Deaconess Medical Center, Inc. | Method of selecting pluripotent hematopioetic progenitor cells |
US5665557A (en) | 1994-11-14 | 1997-09-09 | Systemix, Inc. | Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof |
MX9701512A (en) * | 1994-11-16 | 1997-05-31 | Amgen Inc | Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells. |
US5914268A (en) | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5874301A (en) | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5789147A (en) | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
HUP9801443A3 (en) | 1995-04-27 | 2001-11-28 | Procter & Gamble | Carrier substrate treated with high internal water phase inverse emulsion made with an organopolysiloxane-polyoxyalkylene emulsifier |
US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
US5830708A (en) | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
WO1996040875A1 (en) | 1995-06-07 | 1996-12-19 | Novartis Ag | Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
US6306575B1 (en) | 1995-06-16 | 2001-10-23 | Stemcell Technologies, Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5877299A (en) * | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5654381A (en) | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
US5922597A (en) | 1995-11-14 | 1999-07-13 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
PT868505E (en) | 1995-11-16 | 2005-06-30 | Univ Case Western Reserve | IN VITRO CONDROGENIC INDUCTION OF HUMAN MESENCHINEAL STAMINA CELLS |
US6337387B1 (en) * | 1995-11-17 | 2002-01-08 | Asahi Kasei Kabushiki Kaisha | Differentiation-suppressive polypeptide |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
AU731468B2 (en) * | 1996-04-19 | 2001-03-29 | Mesoblast International Sarl | Regeneration and augmentation of bone using mesenchymal stem cells |
JP2000508922A (en) | 1996-04-26 | 2000-07-18 | ケース ウエスターン リザーブ ユニバーシティ | Skin regeneration using mesenchymal stem cells |
US5919176A (en) * | 1996-05-14 | 1999-07-06 | Children's Hospital Medical Center Of Northern California | Apparatus and method for collecting blood from an umbilical cord |
US5798368A (en) | 1996-08-22 | 1998-08-25 | Celgene Corporation | Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levels |
UA60308C2 (en) | 1996-07-24 | 2003-10-15 | Селджін Корпорейшн | Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxoisoindolines and a method for reducing the level of ТNF-a |
US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
HU228769B1 (en) | 1996-07-24 | 2013-05-28 | Celgene Corp | Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha |
US6281230B1 (en) | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
KR100539031B1 (en) | 1996-08-12 | 2005-12-27 | 셀진 코포레이션 | Novel immunotherapeutic agents and their use in the reduction of cytokine levels |
US5851984A (en) | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
US5916202A (en) * | 1996-08-30 | 1999-06-29 | Haswell; John N. | Umbilical cord blood collection |
US6227202B1 (en) | 1996-09-03 | 2001-05-08 | Maulana Azad Medical College | Method of organogenesis and tissue regeneration/repair using surgical techniques |
US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
US5919702A (en) | 1996-10-23 | 1999-07-06 | Advanced Tissue Science, Inc. | Production of cartilage tissue using cells isolated from Wharton's jelly |
US5969105A (en) | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US6152142A (en) | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
US6231880B1 (en) | 1997-05-30 | 2001-05-15 | Susan P. Perrine | Compositions and administration of compositions for the treatment of blood disorders |
US6261549B1 (en) | 1997-07-03 | 2001-07-17 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
CA2296704C (en) | 1997-07-14 | 2010-10-19 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
US7514074B2 (en) | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
US6077708A (en) | 1997-07-18 | 2000-06-20 | Collins; Paul C. | Method of determining progenitor cell content of a hematopoietic cell culture |
US5879318A (en) * | 1997-08-18 | 1999-03-09 | Npbi International B.V. | Method of and closed system for collecting and processing umbilical cord blood |
WO1999011287A1 (en) * | 1997-09-04 | 1999-03-11 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
US5955476A (en) | 1997-11-18 | 1999-09-21 | Celgene Corporation | Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels |
US5874448A (en) | 1997-11-18 | 1999-02-23 | Celgene Corporation | Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels |
US6248587B1 (en) | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
US6059968A (en) | 1998-01-20 | 2000-05-09 | Baxter International Inc. | Systems for processing and storing placenta/umbilical cord blood |
US6291240B1 (en) | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
CA2323073C (en) * | 1998-03-13 | 2010-06-22 | Osiris Therapeutics, Inc. | Uses for human non-autologous mesenchymal stem cells |
TR200101502T2 (en) | 1998-03-16 | 2002-06-21 | Celgene Corporation | 2- (2,6-dioxopiperidin-3-yl) isoindoline derivatives, their preparation and use as inhibitors of inflammatory cytokines |
US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
ATE316795T1 (en) | 1998-03-18 | 2006-02-15 | Osiris Therapeutics Inc | MESENCHYMAL STEM CELLS FOR THE PREVENTION AND TREATMENT OF IMMUNE RESPONSE DURING TRANSPLANTATIONS |
DE69910362T2 (en) | 1998-04-03 | 2004-06-24 | Osiris Therapeutics, Inc. | APPLICATION OF THE MESENCHYMAL STEM CELLS AS IMMUNE SUPPRESSIVA |
JP2002513762A (en) | 1998-05-04 | 2002-05-14 | ポイント セラピューティクス, インコーポレイテッド | Hematopoietic stimulation |
US6835377B2 (en) | 1998-05-13 | 2004-12-28 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration |
US6225119B1 (en) | 1998-05-22 | 2001-05-01 | Osiris Therapeutics, Inc. | Production of megakaryocytes by the use of human mesenchymal stem cells |
US6387367B1 (en) | 1998-05-29 | 2002-05-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
AU4336599A (en) * | 1998-06-08 | 1999-12-30 | Osiris Therapeutics, Inc. | (in vitro) maintenance of hematopoietic stem cells |
US6255112B1 (en) | 1998-06-08 | 2001-07-03 | Osiris Therapeutics, Inc. | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
US6713245B2 (en) | 1998-07-06 | 2004-03-30 | Diacrin, Inc. | Methods for storing neural cells such that they are suitable for transplantation |
WO2000006150A1 (en) * | 1998-07-28 | 2000-02-10 | Synergen Ag | Use of creatine compounds for treatment of bone or cartilage cells and tissues |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
JP3517359B2 (en) | 1998-09-14 | 2004-04-12 | テルモ株式会社 | Cell separation / collection apparatus and cell separation / collection method |
WO2000017325A1 (en) | 1998-09-23 | 2000-03-30 | Mount Sinai Hospital | Trophoblast cell preparations |
WO2000027995A1 (en) | 1998-11-09 | 2000-05-18 | Monash University | Embryonic stem cells |
US6548299B1 (en) * | 1999-11-12 | 2003-04-15 | Mark J. Pykett | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
AU1720400A (en) | 1998-11-12 | 2000-05-29 | Cell Science Therapeutics, Inc. | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US6102871A (en) | 1998-11-23 | 2000-08-15 | Coe; Rosemarie O. | Blood collection funnel |
US6328765B1 (en) | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
ES2224726T3 (en) | 1998-12-24 | 2005-03-01 | Biosafe S.A. | BLOOD SEPARATION SYSTEM INDICATED IN PARTICULAR FOR THE CONCENTRATION OF HEMATOPOYETIC MOTHER CELLS. |
WO2000055134A1 (en) | 1999-03-18 | 2000-09-21 | Celgene Corporation | Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
EP1194463B1 (en) | 1999-04-16 | 2009-11-11 | Wm. MARSH RICE UNIVERSITY | Poly(propylene fumarate) cross linked with poly(ethylene glycol)-dimethacrylate |
IN191359B (en) | 1999-04-20 | 2003-11-29 | Nat Inst Immunology | |
AU4860900A (en) | 1999-06-02 | 2000-12-18 | Lifebank Services, L.L.C. | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
US6333029B1 (en) * | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
US8147824B2 (en) | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US6239157B1 (en) | 1999-09-10 | 2001-05-29 | Osiris Therapeutics, Inc. | Inhibition of osteoclastogenesis |
US6685936B2 (en) | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US6280718B1 (en) | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
DE19954421A1 (en) | 1999-11-12 | 2001-05-31 | Lohmann Therapie Syst Lts | Film-like preparation for the biphase release of pharmacologically active or other substances |
DE10001172A1 (en) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templating solid particles with polymer multilayers |
EP1264877B1 (en) | 2000-03-16 | 2013-10-02 | Cellseed Inc. | Cell cultivation-support material, method of cocultivation of cells and cocultivated cell sheet obtained therefrom |
WO2001075094A1 (en) | 2000-04-04 | 2001-10-11 | Thomas Jefferson University | Application of myeloid-origin cells to the nervous system |
EP1289557B1 (en) | 2000-06-06 | 2006-07-12 | Glaxo Group Limited | Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor |
US20050009876A1 (en) * | 2000-07-31 | 2005-01-13 | Bhagwat Shripad S. | Indazole compounds, compositions thereof and methods of treatment therewith |
JP2002045174A (en) | 2000-07-31 | 2002-02-12 | Inst Of Physical & Chemical Res | Method for proliferating natural killer cell |
US6458810B1 (en) | 2000-11-14 | 2002-10-01 | George Muller | Pharmaceutically active isoindoline derivatives |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20080152629A1 (en) | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
US7091353B2 (en) | 2000-12-27 | 2006-08-15 | Celgene Corporation | Isoindole-imide compounds, compositions, and uses thereof |
US20030045552A1 (en) | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
EP1367899A4 (en) | 2001-02-14 | 2004-07-28 | Leo T Furcht | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
NZ528035A (en) | 2001-02-14 | 2005-07-29 | Robert J Hariri | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
US20020132343A1 (en) | 2001-03-19 | 2002-09-19 | Clark Lum | System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation |
US20030044977A1 (en) * | 2001-08-10 | 2003-03-06 | Norio Sakuragawa | Human stem cells originated from human amniotic mesenchymal cell layer |
DE10139783C1 (en) | 2001-08-14 | 2003-04-17 | Transtissue Technologies Gmbh | Cell compositions for the treatment of osteoarthritis, and methods for their production |
WO2003018780A1 (en) * | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
EP1288293A1 (en) | 2001-08-30 | 2003-03-05 | Norio Sakuragawa | Human neural stem cells originated from human amniotic mesenchymal cell layer |
CN1195055C (en) | 2001-09-06 | 2005-03-30 | 周胜利 | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
DE60233248D1 (en) | 2001-11-15 | 2009-09-17 | Childrens Medical Center | PROCESS FOR THE ISOLATION, EXPANSION AND DIFFERENTIATION OF FEDERAL STRAIN CELLS FROM CHORION ZOTTE, FRUIT WATER AND PLAZENTA AND THERAPEUTIC USES THEREOF |
JP3728750B2 (en) | 2001-11-22 | 2005-12-21 | ニプロ株式会社 | Cultured skin and method for producing the same |
US7799324B2 (en) | 2001-12-07 | 2010-09-21 | Geron Corporation | Using undifferentiated embryonic stem cells to control the immune system |
JP3934539B2 (en) | 2001-12-12 | 2007-06-20 | 独立行政法人科学技術振興機構 | Adult or postnatal tissue progenitor cells derived from placenta |
WO2003061591A2 (en) * | 2002-01-22 | 2003-07-31 | Advanced Cell Technology, Inc. | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
MXPA04007732A (en) | 2002-02-13 | 2004-10-15 | Anthrogenesis Corp | Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells. |
US7736892B2 (en) | 2002-02-25 | 2010-06-15 | Kansas State University Research Foundation | Cultures, products and methods using umbilical cord matrix cells |
US20030161818A1 (en) | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
WO2003077865A2 (en) | 2002-03-15 | 2003-09-25 | Baxter International Inc. | Methods and compositions for directing cells to target organs |
US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
CA2481385A1 (en) | 2002-04-12 | 2003-10-23 | Celgene Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
KR20050000398A (en) | 2002-04-12 | 2005-01-03 | 셀진 코포레이션 | Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
CA2483010A1 (en) | 2002-04-19 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Placental derived stem cells and uses thereof |
US20040161419A1 (en) | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
KR100793564B1 (en) * | 2002-05-17 | 2008-01-14 | 셀진 코포레이션 | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
EP1525308A4 (en) * | 2002-05-30 | 2006-11-02 | Celgene Corp | Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
US7422736B2 (en) | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
JP4603883B2 (en) | 2002-07-31 | 2010-12-22 | サントル・ナショナル・ドゥ・ラ・レシェルシュ・サイエンティフィーク−セ・エン・エール・エス− | Stem cells derived from adipose tissue and cells differentiated from the cells |
EP1535994A4 (en) | 2002-08-23 | 2005-12-07 | Srl Inc | Human bone stem cells |
US20040062753A1 (en) | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
EP1571910A4 (en) | 2002-11-26 | 2009-10-28 | Anthrogenesis Corp | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
DE602004028803D1 (en) | 2003-02-11 | 2010-10-07 | John E Davies | PRECURSOR CELLS FROM THE WHARTON SULCE OF HUMAN NECK LOCKS |
NZ542127A (en) | 2003-02-13 | 2008-04-30 | Anthrogenesis Corp | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
WO2004087896A2 (en) | 2003-03-31 | 2004-10-14 | Pfizer Products Inc. | Hepatocyte differentiation of stem cells |
CN1548529A (en) | 2003-05-09 | 2004-11-24 | 中国人民解放军军事医学科学院基础医 | Separation method of buffering stem cell in human placenta |
WO2005038012A2 (en) | 2003-06-27 | 2005-04-28 | Ethicon Incorporated | Cartilage and bone repair and regeneration using postpartum-derived cells |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
CN1233822C (en) * | 2003-09-05 | 2005-12-28 | 中国科学技术大学 | Interleukin-15 gene modified natural killing cell strain and its preparation method |
JP4152840B2 (en) | 2003-09-11 | 2008-09-17 | 太陽誘電株式会社 | Communication device |
US20050089513A1 (en) | 2003-10-28 | 2005-04-28 | Norio Sakuragawa | Side population cells originated from human amnion and their uses |
WO2005047491A2 (en) | 2003-11-10 | 2005-05-26 | Amgen Inc. | Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
KR100560340B1 (en) | 2003-11-11 | 2006-03-14 | 한훈 | Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood |
JP2005151907A (en) | 2003-11-27 | 2005-06-16 | Shigeo Saito | Human stem cell derived from placenta or amnion and method for establishing the same and method for differentiation-induction to organ |
TWI338714B (en) | 2003-12-02 | 2011-03-11 | Cathay General Hospital | Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid |
KR20110116225A (en) | 2003-12-02 | 2011-10-25 | 셀진 코포레이션 | Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
US20050176139A1 (en) | 2004-01-12 | 2005-08-11 | Yao-Chang Chen | Placental stem cell and methods thereof |
US20050266391A1 (en) | 2004-01-15 | 2005-12-01 | Bennett Brydon L | Methods for preserving tissue |
WO2005093044A1 (en) | 2004-03-22 | 2005-10-06 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
NZ550027A (en) | 2004-03-26 | 2009-03-31 | Celgene Corp | Systems and methods for providing a stem cell bank |
WO2005105982A1 (en) | 2004-03-31 | 2005-11-10 | Reinhardt Schwartz-Albiez | Method for the ex vivo sequential expansion of human postembryonic stem cells and subsequent selective differentiation |
WO2005105992A1 (en) | 2004-04-21 | 2005-11-10 | New York Eye & Ear Infirmary | Chondrocyte culture formulations |
JP2006006249A (en) | 2004-06-28 | 2006-01-12 | Hiroshima Univ | Method for culturing amnion-derived cell and utilization of the same |
US7244759B2 (en) | 2004-07-28 | 2007-07-17 | Celgene Corporation | Isoindoline compounds and methods of making and using the same |
US20080292597A1 (en) | 2004-07-29 | 2008-11-27 | David A Steenblock | Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases |
CA2971062C (en) | 2004-08-16 | 2019-02-26 | Cellresearch Corporation Pte Ltd | Isolation of stem/progenitor cells from amniotic membrane of umbilical cord |
US7909806B2 (en) * | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
US7147626B2 (en) * | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
US8039258B2 (en) | 2004-09-28 | 2011-10-18 | Ethicon, Inc. | Tissue-engineering scaffolds containing self-assembled-peptide hydrogels |
US20060171930A1 (en) | 2004-12-21 | 2006-08-03 | Agnieszka Seyda | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
US20060166361A1 (en) | 2004-12-21 | 2006-07-27 | Agnieszka Seyda | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
CA2589063C (en) | 2004-12-23 | 2016-08-09 | Ethicon Incorporated | Treatment of parkinson's disease and related disorders using postpartum derived cells |
PL1831356T3 (en) | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20070041943A1 (en) | 2004-12-29 | 2007-02-22 | Children's Hospital Research | Expression of virus entry inhibitors and recombinant AAV thereof |
US9056093B2 (en) | 2005-01-07 | 2015-06-16 | Wake Forest University Health Sciences | Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
WO2006091766A2 (en) | 2005-02-24 | 2006-08-31 | Jau-Nan Lee | Human trophoblast stem cells and use thereof |
GB0503918D0 (en) * | 2005-02-25 | 2005-04-06 | Erasmus University | Cell |
US20060222634A1 (en) | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
WO2006111706A1 (en) | 2005-04-16 | 2006-10-26 | Axordia Limited | Cytotrophoblast stem cell |
AU2006202209B2 (en) | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
ZA200800144B (en) * | 2005-06-10 | 2010-02-24 | Celgene Corp | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
KR20080026198A (en) * | 2005-06-30 | 2008-03-24 | 안트로제네시스 코포레이션 | Repair of tympanic membrane using placenta derived collagen biofabric |
WO2007009062A2 (en) | 2005-07-13 | 2007-01-18 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
WO2007009061A2 (en) * | 2005-07-13 | 2007-01-18 | Anthrogenesis Corporation | Ocular plug formed from placenta derived collagen biofabric |
US20080226612A1 (en) | 2005-08-19 | 2008-09-18 | Bio Regenerate, Inc. | Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
WO2007032634A1 (en) | 2005-09-12 | 2007-03-22 | Industry Foundation Of Chonnam National University | A method for production of mature natural killer cell |
ES2502841T3 (en) | 2005-09-28 | 2014-10-06 | Ipd-Therapeutics B.V. | Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics |
ES2452595T3 (en) | 2005-10-13 | 2014-04-02 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
EP2368973A1 (en) | 2005-10-13 | 2011-09-28 | Anthrogenesis Corporation | Production Of Oligodendrocytes From Placenta-Derived Stem Cells |
CN100344757C (en) | 2005-10-18 | 2007-10-24 | 天津昂赛细胞基因工程有限公司 | Human placenta, umbilical cord mesenchyma stemcell stock and its construction method |
WO2007070870A1 (en) | 2005-12-16 | 2007-06-21 | Ethicon, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
EP1976975B1 (en) | 2005-12-19 | 2012-08-01 | Ethicon, Inc. | In vitro expansion of postpartum derived cells in roller bottles |
JP2009520466A (en) | 2005-12-22 | 2009-05-28 | エニス,ジエーン | Viable cells from frozen umbilical cord tissue |
EP1979050B1 (en) | 2005-12-28 | 2017-04-19 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using postpartum-derived cells |
EP1974013A2 (en) | 2005-12-29 | 2008-10-01 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
US8455250B2 (en) | 2005-12-29 | 2013-06-04 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
PL2471904T3 (en) | 2005-12-29 | 2019-08-30 | Celularity, Inc. | Placental stem cell populations |
US20070253931A1 (en) | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
DK2463305T3 (en) * | 2006-01-12 | 2016-08-29 | Alexion Pharma Inc | Antibodies to OX-2 / CD200 and uses thereof |
US9944900B2 (en) | 2006-01-18 | 2018-04-17 | Hemacell Perfusion | Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells |
WO2007087293A2 (en) | 2006-01-23 | 2007-08-02 | Athersys, Inc. | Mapc therapeutics without adjunctive immunosuppressive treatment |
ZA200810412B (en) * | 2006-06-09 | 2010-03-31 | Anthrogenesis Corp | Placental niche and use thereof to culture stem cells |
US20070287176A1 (en) | 2006-06-13 | 2007-12-13 | Alireza Rezania | Chorionic villus derived cells |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
WO2008021391A1 (en) * | 2006-08-15 | 2008-02-21 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
US8122763B2 (en) | 2006-09-01 | 2012-02-28 | Avair, Llc | Breathing gas supply visual broadcast apparatus |
WO2008042441A1 (en) | 2006-10-03 | 2008-04-10 | Anthrogenesis Corporation | Use of umbilical cord biomaterial for ocular surgery |
WO2008060377A2 (en) | 2006-10-04 | 2008-05-22 | Anthrogenesis Corporation | Placental or umbilical cord tissue compositions |
CA3178363A1 (en) | 2006-10-06 | 2008-05-15 | Celularity Inc. | Human placental collagen compositions, and methods of making and using the same |
CA2850793A1 (en) | 2006-10-23 | 2008-05-02 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
CN101611139B (en) | 2006-11-13 | 2012-07-04 | 伊西康公司 | In vitro expansion of postpartum-derived cells using microcarriers |
EP2129775A1 (en) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
AU2008216749B2 (en) | 2007-02-12 | 2014-03-13 | Celularity Inc. | Treatment of inflammatory diseases using placental stem cells |
DK2142642T3 (en) | 2007-03-27 | 2017-09-11 | Ipd-Therapeutics B V | METHODS AND AGENTS FOR STEM CELL PROLIFERATION AND SUBSEQUENT GENERATION AND EXPANSION OF PROGENITOR CELLS, AS WELL AS PRODUCTION OF EFFECT CELLS AS CLINICAL THERAPEUTICS |
US20100172830A1 (en) | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
US8385345B2 (en) | 2007-09-19 | 2013-02-26 | At&T Intellectual Property Ii, L.P. | Data forwarding in hybrid mesh networks |
KR20220122774A (en) | 2007-09-26 | 2022-09-02 | 셀룰래리티 인코포레이티드 | Angiogenic cells from human placental perfusate |
EP2783692B1 (en) | 2007-09-28 | 2019-01-02 | Celularity, Inc. | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
MX2010005018A (en) | 2007-11-07 | 2010-05-27 | Anthrogenesis Corp | Treatment of premature birth complications. |
US20090123442A1 (en) | 2007-11-09 | 2009-05-14 | Avaris Ab | Expanded nk cells |
EP2235162B1 (en) | 2008-01-08 | 2014-10-15 | The University Of Queensland | Method of producing a population of cells |
KR101133185B1 (en) | 2008-07-29 | 2012-04-06 | 서울대학교병원 | Method for Proliferating Natural Killer cell |
MX2011001990A (en) * | 2008-08-20 | 2011-03-29 | Anthrogenesis Corp | Improved cell composition and methods of making the same. |
CN105796602A (en) * | 2008-08-20 | 2016-07-27 | 人类起源公司 | Treatment of stroke using isolated placental cells |
CN102176919A (en) * | 2008-08-22 | 2011-09-07 | 人类起源公司 | Methods and compositions for treatment of bone defects with placental cell populations |
EP2336303B1 (en) | 2008-09-08 | 2015-07-15 | Riken | NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM |
KR20110086176A (en) | 2008-11-19 | 2011-07-27 | 안트로제네시스 코포레이션 | Amnion derived adherent cells |
MX2011005230A (en) | 2008-11-21 | 2011-06-16 | Anthrogenesis Corp | Treatment of diseases, disorders or conditions of the lung using placental cells. |
EP2398897B1 (en) | 2009-02-20 | 2017-06-28 | Cellular Dynamics International, Inc. | Methods and compositions for the differentiation of stem cells |
NZ595440A (en) | 2009-03-25 | 2014-05-30 | Anthrogenesis Corp | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
JP2012521215A (en) | 2009-03-26 | 2012-09-13 | アヴァリス・アクチエボラーグ | Proliferation of NK cells |
US20100323446A1 (en) | 2009-06-05 | 2010-12-23 | Jill Renee Barnett | Method of collecting placental cells |
CA2767014C (en) * | 2009-07-02 | 2022-01-25 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
ES2646750T3 (en) | 2010-01-26 | 2017-12-15 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
US20110280849A1 (en) | 2010-03-26 | 2011-11-17 | Anthrogenesis Corporation | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
SI2556145T1 (en) | 2010-04-07 | 2017-01-31 | Anthrogenesis Corporation | Angiogenesis using placental stem cells |
KR20130092394A (en) | 2010-04-08 | 2013-08-20 | 안트로제네시스 코포레이션 | Treatment of sarcoidosis using placental stem cells |
NZ605505A (en) * | 2010-07-13 | 2015-02-27 | Anthrogenesis Corp | Methods of generating natural killer cells |
WO2012075412A1 (en) | 2010-12-03 | 2012-06-07 | Michael Verneris | Generation of natural killer cells and lymphoid tissue inducer-like (lti-like) nk-22 cells |
AU2011342904B2 (en) | 2010-12-17 | 2016-05-12 | Biolamina Ab | Cell culture medium |
US20120171295A1 (en) | 2010-12-30 | 2012-07-05 | Sascha Abramson | Methods for cryopreserving and encapsulating cells |
WO2012092458A2 (en) | 2010-12-30 | 2012-07-05 | Anthrogenesis Corporation | Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof |
AR093183A1 (en) | 2010-12-31 | 2015-05-27 | Anthrogenesis Corp | INCREASE IN THE POWER OF PLACENTA MOTHER CELLS USING MODULATING RNA MOLECULES |
EP3443968A1 (en) | 2011-06-01 | 2019-02-20 | Celularity, Inc. | Treatment of pain using placental stem cells |
-
2008
- 2008-09-29 EP EP13188706.9A patent/EP2783692B1/en active Active
- 2008-09-29 NZ NZ584458A patent/NZ584458A/en unknown
- 2008-09-29 ES ES13188706T patent/ES2719931T3/en active Active
- 2008-09-29 ES ES08834753T patent/ES2530995T3/en active Active
- 2008-09-29 EP EP18215553.1A patent/EP3524253A1/en not_active Withdrawn
- 2008-09-29 WO PCT/US2008/011251 patent/WO2009045360A2/en active Application Filing
- 2008-09-29 NZ NZ599825A patent/NZ599825A/en unknown
- 2008-09-29 KR KR1020197034127A patent/KR20190132556A/en not_active Application Discontinuation
- 2008-09-29 CA CA2700617A patent/CA2700617C/en active Active
- 2008-09-29 KR KR1020157019757A patent/KR20150088336A/en not_active Application Discontinuation
- 2008-09-29 RU RU2010116757/15A patent/RU2536242C2/en active
- 2008-09-29 US US12/240,956 patent/US8263065B2/en active Active
- 2008-09-29 EP EP08834753.9A patent/EP2203176B1/en active Active
- 2008-09-29 PL PL08834753T patent/PL2203176T3/en unknown
- 2008-09-29 KR KR1020167021613A patent/KR20160098527A/en not_active Application Discontinuation
- 2008-09-29 HU HUE08834753A patent/HUE024286T2/en unknown
- 2008-09-29 RS RS20150132A patent/RS53841B1/en unknown
- 2008-09-29 KR KR1020107009228A patent/KR101648589B1/en active IP Right Grant
- 2008-09-29 BR BRPI0817751A patent/BRPI0817751A2/en not_active Application Discontinuation
- 2008-09-29 KR KR1020237014071A patent/KR20230065354A/en not_active Application Discontinuation
- 2008-09-29 KR KR1020177025849A patent/KR101955140B1/en active IP Right Grant
- 2008-09-29 SI SI200831388T patent/SI2203176T1/en unknown
- 2008-09-29 KR KR1020227028095A patent/KR20220119515A/en not_active Application Discontinuation
- 2008-09-29 KR KR1020217004990A patent/KR20210022148A/en not_active Application Discontinuation
- 2008-09-29 MX MX2010003291A patent/MX2010003291A/en active IP Right Grant
- 2008-09-29 CN CN201310495664.5A patent/CN103599132A/en active Pending
- 2008-09-29 PT PT08834753T patent/PT2203176E/en unknown
- 2008-09-29 KR KR1020187027232A patent/KR20180107320A/en not_active Application Discontinuation
- 2008-09-29 AU AU2008307633A patent/AU2008307633C1/en active Active
- 2008-09-29 JP JP2010526968A patent/JP5795476B2/en active Active
- 2008-09-29 MX MX2013000346A patent/MX349144B/en unknown
- 2008-09-29 CA CA3018281A patent/CA3018281C/en active Active
- 2008-09-29 DK DK08834753.9T patent/DK2203176T3/en active
- 2008-09-29 NZ NZ617412A patent/NZ617412A/en unknown
- 2008-09-29 DK DK13188706.9T patent/DK2783692T3/en active
- 2008-09-29 KR KR1020217033153A patent/KR20210127819A/en not_active Application Discontinuation
- 2008-09-29 CN CN2008801183996A patent/CN101878034B/en active Active
- 2008-09-29 CN CN201310145616.3A patent/CN103356702B/en active Active
-
2010
- 2010-03-28 IL IL204860A patent/IL204860A/en active IP Right Grant
- 2010-03-31 ZA ZA2010/02304A patent/ZA201002304B/en unknown
- 2010-07-09 HK HK10106693.5A patent/HK1139876A1/en unknown
-
2012
- 2012-08-13 US US13/584,612 patent/US9216200B2/en active Active
-
2015
- 2015-01-09 JP JP2015003222A patent/JP6148262B2/en active Active
- 2015-02-26 HR HRP20150220AT patent/HRP20150220T1/en unknown
- 2015-03-31 HK HK15103283.3A patent/HK1202460A1/en unknown
- 2015-11-16 US US14/942,337 patent/US20160287635A1/en not_active Abandoned
-
2016
- 2016-06-15 JP JP2016119378A patent/JP6616248B2/en active Active
-
2017
- 2017-01-26 IL IL250316A patent/IL250316A0/en unknown
-
2019
- 2019-07-03 JP JP2019124571A patent/JP2019206532A/en not_active Withdrawn
-
2022
- 2022-01-07 JP JP2022001651A patent/JP2022062020A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7045148B2 (en) * | 2000-12-06 | 2006-05-16 | Anthrogenesis Corporation | Method of collecting placental stem cells |
US7255879B2 (en) * | 2000-12-06 | 2007-08-14 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US20030068306A1 (en) * | 2001-09-14 | 2003-04-10 | Dilber Mehmet Sirac | Medium |
US20070041954A1 (en) * | 2005-07-14 | 2007-02-22 | Ichim Thomas E | Compositions of placentally-derived stem cells for the treatment of cancer |
Non-Patent Citations (2)
Title |
---|
ROUSSEV R G ET AL: "Phenotypic characterization of normal human placental mononuclear cells", JOURNAL OF REPRODUCTIVE IMMUNOLOGY, ELSEVIER SCIENCE IRELAND LTD, IE, vol. 25, no. 1, 1 September 1993 (1993-09-01), pages 15 - 29, XP023688512, ISSN: 0165-0378, [retrieved on 19930901] * |
TAKAHASHI E ET AL: "Induction of CD16(+) CD56(bright) NK cells with antitumour cytotoxicity not only from CD16(-) CD56(bright) NK cells but also from CD16(-) CD56(dim) NK cells", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, vol. 65, no. 2, February 2007 (2007-02-01), pages 126 - 138, XP002528954, ISSN: 0300-9475 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009045360A3 (en) | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells | |
MX2009001311A (en) | Tumor suppression using placental stem cells. | |
WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
WO2008036374A3 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
WO2006118914A3 (en) | Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition | |
HK1109783A1 (en) | Use of cultured three-dimensional tissue for treating congestive heart failure | |
WO2006133271A3 (en) | Compositions and methods relating to target-specific photodynamic therapy | |
AU2003273276A1 (en) | Methods and compositions for the preservation of cells, tissues or organs in the vitreous state | |
SG148171A1 (en) | Methods of proliferating stem cells | |
AU2018253575A1 (en) | Natural killer cells from placenta | |
WO2010062762A3 (en) | Compositions and methods for reducing the signs of aging of the skin | |
EP1993592A4 (en) | Compositions containing lactoferrin, and methods of using same to promote growth of skin cells | |
WO2008132021A3 (en) | Fungicide mixtures | |
WO2007041564A3 (en) | (s)-6-methyloxaalkyl exemestane compounds and related methods of use | |
WO2007116404A3 (en) | Cucurbitacin glucosides and use thereof in treating cancer | |
WO2006062935A3 (en) | Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin | |
WO2007025166A3 (en) | Devices, compositions and methods for the protection and repair of cells and tissues | |
NZ595440A (en) | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds | |
WO2008060945A3 (en) | Diagnosis and treatment of breast cancer | |
WO2008016730A3 (en) | Compositions and methods for reducing cellular fat | |
WO2009047568A3 (en) | In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells | |
WO2007082001A3 (en) | Extract of r. miehei | |
WO2012074676A3 (en) | Glp-1 agonists, dpp-4 inhibitors, compositions, and uses related thereto | |
WO2005032595A3 (en) | Methods and compositions for the inhibition of stat5 in prostate cancer cells | |
WO2007124125A3 (en) | Methods of identifying stem cells in normal and cancerous tissues and related progeny cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2010/003291 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200880118399.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08834753 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2700617 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010526968 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008307633 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 584458 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2296/CHENP/2010 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 20107009228 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008834753 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010116757 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2008307633 Country of ref document: AU Date of ref document: 20080929 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-2015/0132 Country of ref document: RS |
|
WWE | Wipo information: entry into national phase |
Ref document number: 250316 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: PI0817751 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100326 |